Clinical Trial Update: Safety of Active Immunotherapy in Subjects With Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the safety of an active immunotherapy in subjects with ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Life Research Technologies GmbH | Conditions: Ovarian Epithelial Cancer | Phase 1 | Status: UNKNOWN